THE NEW POSSIBLE
November 14 – 15, 2018 • Harvard Medical School, Boston, MA
The 14th Annual Personalized Medicine Conference: Preparing for the New Possible will convene the world’s leading researchers, investors, industry executives, policy experts, payers, clinicians, and patient advocates to define the landscape and outlook for personalized medicine in science, business, and policy. Participants will examine the infrastructure and business strategies necessary to overcome scientific obstacles, optimize public policies, and change embedded medical norms as we seek to accelerate investment in and adoption of personalized medicine.
The successful implementation of [personalized medicine] will depend on the embrace of [its] principles in the business community.”— Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Harvard Medical School
Amy P. Abernethy, M.D., Ph.D.
Chief Medical Officer, Chief Scientific Officer
Donna R. Cryer, J.D.
Global Liver Institute
Richard Hamermesh, D.B.A.
Harvard Business School Kraft Precision Medicine Accelerator
Chairman, CEO, Co-founder
David King, J.D.
Daniel P. O’Day
Scott D. Ramsey, M.D., Ph.D.
Full Member; Director
Fred Hutchinson Cancer Research Center; Hutchinson Institute for Cancer Outcomes Research
Ellen V. Sigal, Ph.D.
Friends of Cancer Research